United States Bio-Betters Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Amgen Inc, Novo Nordisk A/S, Celltrion, Inc, Altos Biologics Co, Genentech USA

The Bio-Betters Market size grew from US$ 49.87 billion in 2023 to US$ 53.73 billion in 2024 and is projected to reach US$ 110.46 billion by 2033, expanding at a CAGR of 8.5% during the forecast period 2025-2033.

DataM Intelligence has published a new research report on "Biobetters Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/biobetters-market?sg

Key Players: Celltrion, Inc., Altos Biologics Co., Ltd., Amgen Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi SA, and Genentech USA, Inc.

Industry Latest News:

✅ Jan 14, 2025 - Celltrion unveiled a strategic drug-development roadmap at the JP Morgan conference, highlighting plans to advance next-generation antibody drug conjugates (ADCs) and multispecific antibodies (13 IND submissions planned through 2028).

✅ Feb 3, 2025 - BioNTech completed its acquisition of Biotheus, giving BioNTech in-house bispecific/ADC capabilities and full rights to Biotheus' oncology assets (including the BNT327 program). This strengthens BioNTech's ability to develop differentiated biologics.

✅ (2025 - reported / contractual dates in H1-mid-2025) - BioNTech - Bristol Myers Squibb (BMS) collaboration / deal on the BNT327 oncology candidate (multi-billion dollar partnership to co-develop/commercialize a bispecific/engineered antibody). This is a major out-licensing / partnership that accelerates a next-generation biologic toward late-stage development and potential launch.

✅ Jan 8, 2025 - Roche moved to acquire Poseida Therapeutics (allogeneic CAR-T / cell therapy capabilities) - M&A that broadens Roche's next-generation biologics and cell therapy portfolio; though Poseida is cell-therapy focused, such deals reflect the active 2025 M&A market for advanced biologics.

✅ Mar 12, 2025 - Roche struck a major deal with Zealand Pharma (rights/terms to develop/commercialize petrelintide, a long-acting peptide candidate) - part of broader 2025 activity where large pharmas secured next-generation or potentially differentiated biological/peptide assets.

Growth Forecast Projected:

The Global Biobetters Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Biobetters Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=biobetters-market?sg

Key Segments:

By Type (Monoclonal Antibodies, Insulin Biobetters, Erythropoietin Biobetters, Granulocyte-Colony Stimulating Factor (G-CSF) Biobetters, Anti-Hemophilic Factor Biobetters, and Others)

By Application (Cancer, Diabetes, Autoimmune Diseases, Cardiovascular Diseases, Renal Diseases, Neurodegenerative Diseases, Genetic Disorders, and Others)

By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies)

By Region (North America, Europe, Asia-Pacific, South America and the Middle East & Africa)

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Biobetters producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Biobetters revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/biobetters-market?sg

FAQ's

Q1: What is the current size of the Biobetters Market?

A: The Biobetters Market stood at US$ 53.73 billion in 2024 and is set to experience remarkable growth, reaching US$ 110.46 billion by 2033

Q2: How fast is the Biobetters Market growing?

A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 8.5% from 2025-2033.

Have any Enquiry of This Report @ https://www.datamintelligence.com/enquiry/biobetters-market?sg

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.